Quest Diagnostics Inc (DGX): Long-Term Debt
$5.67B
As of 2025-12-31
$5.64B
As of 2026-06-30
+12.5%
3-year compound annual growth
+7.2%
5-year compound annual growth
+4.5%
10-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.67B | -8.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $6.22B | +31.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $4.71B | +18.4% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $3.98B | -0.8% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $4.01B | -0.1% | 2023-02-21, Balance as of period end |
| 2020-12-31 | $4.01B | -15.8% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $4.77B | +22.5% | 2021-02-22, Balance as of period end |
| 2018-12-31 | $3.89B | +2.9% | 2020-02-20, Balance as of period end |
| 2017-12-31 | $3.78B | +1.3% | 2019-02-21, Balance as of period end |
| 2016-12-31 | $3.73B | +2.3% | 2018-02-23, Balance as of period end |
| 2015-12-31 | $3.65B | -2.4% | 2017-02-22, Balance as of period end |
| 2014-12-31 | $3.74B | +12.3% | 2016-02-26, Balance as of period end |
| 2013-12-31 | $3.33B | -1.0% | 2015-02-24, Balance as of period end |
| 2012-12-31 | $3.36B | -14.6% | 2014-02-18, Balance as of period end |
| 2011-12-31 | $3.94B | +48.7% | 2013-02-27, Balance as of period end |
| 2010-12-31 | $2.65B | n/a | 2011-02-16, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $5.67B | -8.8% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $1.09B | +7.2% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $1.50B | +31.6% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $378.45M | +1.4% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $10.06M | +0.3% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $57.23M | +11.2% |
| Biodesix Inc (BDSX) | 2025-12-31 | $50.01M | +24.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $22.91M | +13.1% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $17.40M | -14.8% |
Compare DGX, RDNT, GH, CAI side by side · Screen every company in Services-Medical Laboratories ↗